Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary Shares, $0.01875 par value
-
Shares outstanding
-
7,902,293
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
98,532
-
Shares change
-
+26,983
-
Total reported value, excl. options
-
$33,654
-
Value change
-
+$9,582
-
Number of buys
-
2
-
Number of sells
-
1
-
Price
-
$0.3596
Institutional Holders of UNIVERSE PHARMACEUTICALS, INC. - Ordinary Shares, $0.01875 par value (UPC) as of Q2 2023
As of 30 Jun 2023 UNIVERSE PHARMACEUTICALS, INC. - Ordinary Shares, $0.01875 par value (UPC) had 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 98,532 shares of stock of the company.
Largest 4 holders included ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA SECURITIES, LLC, and HRT FINANCIAL LP.
This table shows 4 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.